Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman
- PMID: 17009070
- DOI: 10.1007/s00508-006-0655-5
Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman
Abstract
Introduction: Ephedrine or ephedra herbal products have occasionally been used to enhance sports performance and energy or to aid weight loss. The most serious side effects are those on cardiovascular function, including acute myocardial infarction, severe hypertension, myocarditis and lethal cardiac arrhythmias.
Case report: A 19-year-old woman was taking ephedrine to enhance her sports performance. After 10 days of this medication she developed hemodynamically unstable ventricular tachycardia resistant to cardioversion and amiodarone treatment. She converted to sinus rhythm 60 hours later, presumably when the plasma ephedrine level had sufficiently decreased. In an electrophysiological study the ventricular tachycardia could be induced and successfully ablated. There were no recurrences during follow-up of more than a year. The use of ephedrine carries a risk of development of life-threatening arrhythmias.
Discussion: Ephedrine alone cannot be considered as the ultimate cause of tachycardia in our patient; however, it is highly probable that ephedrine triggered the tachycardic attack. The proarrhythmic effect most likely occurred because of underlying idiopathic left ventricular tachycardia. Although the patient could have developed her first attack of ventricular tachycardia at any time in her life, it is highly improbable that the attack following the ephedrine abuse was purely coincidental.
Conclusion: Our experience with the reported patient shows that ephedrine alone, or in combination with substances that increase its effects on the cardiovascular system, may also trigger paroxysms of non-ischemic ventricular tachycardia. The use of ephedrine carries a risk of development of life-threatening arrhythmias and should be discouraged.
Similar articles
-
[Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].Ann Cardiol Angeiol (Paris). 1996 Jan;45(1):18-23. Ann Cardiol Angeiol (Paris). 1996. PMID: 8815771 French.
-
Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes.Heart Vessels. 2015 Mar;30(2):280-3. doi: 10.1007/s00380-013-0455-6. Epub 2014 Jan 4. Heart Vessels. 2015. PMID: 24390726
-
Ventricular tachycardia associated with radiation-induced cardiac sarcoma.Tex Heart Inst J. 2014 Dec 1;41(6):620-5. doi: 10.14503/THIJ-13-3378. eCollection 2014 Dec. Tex Heart Inst J. 2014. PMID: 25593527 Free PMC article. Review.
-
Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.G Ital Cardiol. 1999 May;29(5):514-23. G Ital Cardiol. 1999. PMID: 10367218 Clinical Trial.
-
[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].Z Kardiol. 1996;85 Suppl 6:91-6. Z Kardiol. 1996. PMID: 9064988 Review. German.
Cited by
-
Methylephedrine-induced heart failure in a habitual user of paediatric cough syrup: a case report.Eur Heart J Case Rep. 2020 Apr 27;4(3):1-4. doi: 10.1093/ehjcr/ytaa095. eCollection 2020 Jun. Eur Heart J Case Rep. 2020. PMID: 32617471 Free PMC article.
-
cAMP Response Element Binding Protein Expression in the Hippocampus of Rhesus Macaques with Chronic Ephedrine Addiction.Biomed Res Int. 2017;2017:1931204. doi: 10.1155/2017/1931204. Epub 2017 Oct 18. Biomed Res Int. 2017. PMID: 29181387 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical